SecSonar.com

MiMedx Group, Inc. (MDXG)

MiMedx Group, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

MiMedx Group, Inc. (MDXG) is a Biotechnology company based in US with a market capitalization of $553.3M. Revenue grew 20.0% year-over-year and the company generated $73M in free cash flow. This page tracks MDXG's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 837 employees · IPO Feb 12, 2008

Valuation

Valuation & price

$3.56 · as of May 17, 2026 · -55.3% vs 52w high

11.0

P/E ratio

Latest-FY diluted EPS

2.16

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$7.71$5.51$3.31Jul 25Dec 25Jul 26Jul 7, 25$6.48Jul 9, 25$6.96Jul 11, 25$6.66Jul 15, 25$6.33Jul 17, 25$6.72Jul 21, 25$6.65Jul 23, 25$6.93Jul 25, 25$6.77Jul 29, 25$6.67Jul 31, 25$7.19Aug 4, 25$7.15Aug 6, 25$7.24Aug 11, 25$7.04Aug 13, 25$7.27Aug 15, 25$7.11Aug 19, 25$7.19Aug 21, 25$7.03Aug 25, 25$7.08Aug 27, 25$7.17Aug 29, 25$7.10Sep 3, 25$7.10Sep 5, 25$7.14Sep 9, 25$7.12Sep 11, 25$7.14Sep 16, 25$6.97Sep 18, 25$7.15Sep 22, 25$7.19Sep 24, 25$7.09Sep 26, 25$6.94Sep 30, 25$6.98Oct 2, 25$6.71Oct 6, 25$7.31Oct 8, 25$7.10Oct 10, 25$6.55Oct 14, 25$6.58Oct 16, 25$6.63Oct 21, 25$6.74Oct 23, 25$6.64Oct 27, 25$6.73Oct 29, 25$7.19Oct 31, 25$7.65Nov 4, 25$7.69Nov 6, 25$7.33Nov 10, 25$7.71Nov 12, 25$7.48Nov 14, 25$7.38Nov 18, 25$6.72Nov 20, 25$6.55Nov 25, 25$6.95Nov 28, 25$6.88Dec 2, 25$6.72Dec 4, 25$6.86Dec 8, 25$6.68Dec 10, 25$6.98Dec 12, 25$7.22Dec 16, 25$7.25Dec 18, 25$7.25Dec 22, 25$7.04Dec 24, 25$7.08Dec 29, 25$6.91Jan 2, 26$6.48Jan 6, 26$6.40Jan 8, 26$6.31Jan 12, 26$6.00Jan 14, 26$5.69Jan 16, 26$5.42Jan 21, 26$5.33Jan 23, 26$5.26Jan 27, 26$5.30Jan 29, 26$5.14Feb 2, 26$5.09Feb 4, 26$5.11Feb 9, 26$5.19Feb 11, 26$5.21Feb 13, 26$5.12Feb 18, 26$5.22Feb 20, 26$5.17Feb 24, 26$5.35Feb 26, 26$4.94Mar 2, 26$4.88Mar 4, 26$4.82Mar 6, 26$4.50Mar 10, 26$4.57Mar 12, 26$4.38Mar 17, 26$4.36Mar 19, 26$4.17Mar 23, 26$4.24Mar 25, 26$4.10Mar 27, 26$3.81Mar 31, 26$3.95Apr 2, 26$3.92Apr 7, 26$3.86Apr 9, 26$4.03Apr 13, 26$3.92Apr 15, 26$3.88Apr 17, 26$3.42Apr 22, 26$3.31Apr 24, 26$3.43Apr 28, 26$3.40Apr 30, 26$3.36May 4, 26$3.61May 6, 26$3.66May 8, 26$3.60May 12, 26$3.54May 14, 26$3.55May 18, 26$3.59May 20, 26$3.79May 22, 26$3.62May 28, 26$3.67Jun 1, 26$3.58Jun 3, 26$3.61Jun 5, 26$3.74Jun 9, 26$3.71Jun 11, 26$3.69Jun 15, 26$3.68Jun 17, 26$3.61Jun 22, 26$3.67Jun 24, 26$3.83Jun 26, 26$3.93Jul 2, 26$3.95
$3.0952-week range$7.96
Loading valuation history…

Fundamentals

Key fundamentals

$553.3M

Market cap

20.0%

Revenue growth (YoY)

82.6%

Gross margin

$73M

Free cash flow (USD)

-$143.6M

Net debt

Net cash position

0.6%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$245.0MFY 2017$321.1MFY 2018$359.1MFY 2019$299.3MFY 2020$248.2MFY 2021$242.0MFY 2022$267.8MFY 2023$321.5MFY 2024$348.9MFY 2025$418.6M
$245M$418.6M

Free cash flow by year

2016 → 2025

FY 2016$18.7MFY 2017$57.5MFY 2018$25.8MFY 2019$-41.6MFY 2020$-34.5MFY 2021$-5.2MFY 2022$-19.4MFY 2023$24.8MFY 2024$64.5MFY 2025$73.0M
$18.7M$73M

Gross margin by year

2021 → 2025

FY 202183.6%FY 202282.0%FY 202383.0%FY 202482.8%FY 202582.6%
83.6%82.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 29, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventBylaw AmendmentsJun 16, 2026Filing
  • Quarterly report10-Q FiledApr 29, 2026Filing
  • 8-K eventEarnings ReleaseApr 29, 2026Filing
  • 8-K eventCost Reduction InitiativeApr 16, 2026Filing

Questions

Frequently asked questions

What is MiMedx Group, Inc.'s market cap?

MiMedx Group, Inc. (MDXG) has a market capitalization of $553.3M.

What is MDXG's P/E ratio?

MDXG trades at a price-to-earnings ratio of 11.0, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is MDXG's price-to-book (P/B) ratio?

MDXG trades at 2.16 times book value per share.

Are insiders buying MDXG stock?

SEC Form 4 filings show no open-market insider buys at MiMedx Group, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

ACRS

Aclaris Therapeutics, Inc.

$546.3M

RIGL

Rigel Pharmaceuticals, Inc.

$562.1M

VALN

Valneva SE

$563.3M

ARVN

Arvinas, Inc.

$572M

GYRE

Gyre Therapeutics, Inc.

$572.7M

PRTA

Prothena Corporation plc

$528.8M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.